前列腺癌患者肝炎性假瘤表现为FDG高摄取肝病灶:PET/CT诊断陷阱
70岁前列腺癌患者因新发肝病灶行18F-FDG PET/CT,双病灶呈不均匀高代谢,结合CT疑为肝转移并行手术切除,病理意外证实为肝炎性假瘤。PSA低于生化复发阈值而CRP升高,提示炎症可能干扰PET/CT判读。
要点
- 前列腺癌患者新发FDG高摄取肝病灶需鉴别炎性假瘤,避免误判为转移。
- PSA低于生化复发阈值而CRP升高时,应警惕炎症性病变可能。
- FDG高代谢并非恶性肿瘤特异,病理是确诊肝炎性假瘤的关键。
核心结论
- 肝炎性假瘤可表现为FDG高摄取肝病灶,在前列腺癌患者中易被误诊为肝转移。
研究设计与样本
- 本文为单例病例报告,描述一名70岁前列腺癌患者的诊断与治疗经过。
主要发现
- 增强CT新发现两个疑为转移的肝病灶,18F-FDG PET/CT示双病灶不均匀摄取增高。
- 患者PSA低于生化复发阈值,而C反应蛋白升高。
- 基于CT和FDG高代谢疑为肝局限转移并手术切除,组织病理学意外证实为肝炎性假瘤。
临床怎么用
- 前列腺癌患者出现FDG高摄取肝病灶时,应结合PSA和CRP等炎症指标综合判断,必要时行病理确诊。
局限性
- 单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 70-year-old man with prostate cancer underwent contrast-enhanced CT for lesion characterization, which revealed two newly detected hepatic lesions suspicious for metastasis. The prostate-specific antigen level remained below the threshold for biochemical recurrence, whereas C-reactive protein was elevated. 18 F-FDG PET/CT was performed for metabolic characterization and whole-body evaluation, demonstrating heterogeneous increased uptake in both lesions. On the basis of the CT findings and FDG hypermetabolism, liver-confined metastatic disease was suspected, and surgical resection was performed. Histopathology unexpectedly revealed a hepatic inflammatory pseudotumor.
引用
- Weng Y, Yin H, Shi H, et al. Hepatic Inflammatory Pseudotumor Presenting as FDG-avid Liver Lesions in a Prostate Cancer Patient: A Diagnostic Pitfall on PET/CT. Clin Nucl Med. 2026. PMID: 42302736. doi:10.1097/RLU.0000000000006529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。